Positive Processes and Transition to Health - Single-Session (PATH-SS) (NCT06900712) | Clinical Trial Compass
RecruitingNot Applicable
Positive Processes and Transition to Health - Single-Session (PATH-SS)
United States45 participantsStarted 2025-07-17
Plain-language summary
The goal of this clinical trial is to test a brief, new psychotherapy (called Positive Processes and Transition to Health - Single Session, or PATH-SS) that aims to provide relief for people who are suffering after experiencing a sexual assault. This research will explore whether this new psychotherapy reduces sexual assault related distress, including posttraumatic stress and depression symptoms. The main questions it aims to answer are:
Does PATH-SS leads to improvements in PTSD and depression symptoms (pre- to post- and 1-month follow-up)? Do participants perceive PATH-SS to be acceptable, helpful, and do they complete/adhere to treatment? Participants will complete a pre-treatment/baseline assessment to confirm eligibility, and those who are eligible will receive the single-session intervention and will complete a post-treatment and a 1-month follow-up assessment of stressor-related symptoms.
Who can participate
Age range18 Years β 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
β. Age range: from 18 to 65.
β. Has experienced unwanted sexual contact or sexual assault with a minimum of 12 weeks since the event and a maximum of 5 years since the event.
β. Residence in the state of Ohio.
β. Elevated symptoms on either the Posttraumatic Diagnostic Scale (PDS-5) or the Quick Inventory of Depressive Symptomatology (QIDS-SR), at least moderate: 18 on PDS-5 (Foa et al., 2016) and/or 11 on QIDS (moderate depression severity; Rush et al., 2003), with symptoms persisting for 1 month or longer.
Exclusion criteria
β. Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder as defined by DSM-5.
β. Current diagnosis of bipolar disorder, depression with psychotic features, or depression severe enough to require immediate psychiatric treatment (i.e., serious suicide risk with intent and plan).
β. Severe self-injurious behavior or suicide attempt within the previous three months.
β. Currently engaged in cognitive behavioral psychotherapy.
What they're measuring
1
PTSD Symptom Scale-Interview (PSS-I-5; Foa et al., 2016)
Timeframe: From baseline to follow-up at 1 month after treatment completion
2
Quick Inventory of Depressive Symptomatology-Clinican Report (QIDS-C; Rush et al., 2003)
Timeframe: From baseline to follow-up at 1 month after treatment completion
3
Post-traumatic Stress Diagnostic Scale (PDS-5; Foa et al., 2016)
Timeframe: From baseline to follow-up at 1 month after treatment completion
4
Quick Inventory of Depressive Symptomatology Self-Report Version (QIDS-SR; Rush et al., 2003)
Timeframe: From baseline to follow-up at 1 month after treatment completion